Department of Cardiovascular Diseases, Civil Aviation General Hospital, Civil Aviation Clinical Medical College of Peking University, Beijing, China.
BMJ Open. 2018 Oct 18;8(10):e023459. doi: 10.1136/bmjopen-2018-023459.
This study aimed to evaluate prognostic value of the combination of monocyte-to-lymphocyte ratio (MLR) with neutrophil-to-lymphocyte ratio (NLR) for predicting long-term major adverse cardiac events (MACE) in patients with non-ST elevated myocardial infarction (NSTEMI) who underwent primary percutaneous coronary intervention (PCI).
Retrospective cohort study.
Civil Aviation General Hospital, Beijing, China.
678 patients with NSTEMI undergoing primary PCI between July 2010 and July 2015 were enrolled.
The main outcomes were MACE. The cumulative MACE-free survival rates were calculated by Kaplan-Meier analysis and the independent predictors of MACE were assessed by Cox regression analysis.
According to the cut-off values of MLR 0.36 and NLR 2.15, the study population was classified into four groups: low MLR + low NLR group (n=319), low MLR + high NLR group (n=126), high MLR + low NLR group (n=102) and high MLR + high NLR group (n=131). The high MLR + high NLR group had a lower MACE-free survival rate than the other three groups (p logrank <0.001). Both MLR (HR 2.128, 95% CI 1.458 to 3.105) and NLR (HR 1.925, 95% CI 1.385 to 2.676) were independent predictors of long-term MACE. Moreover, the patients in the high MLR + high NLR group had an HR of 4.055 (95% CI 2.550 to 6.448) for long-term MACE, with the low-MLR + low NLR group as reference. Comparisons of receiver operating characteristic curves revealed that the combination of MLR with NLR achieved better performance in differentiating long-term MACE, compared with MLR, NLR, high-sensitivity C reactive protein and brain natriuretic peptide alone, and had similar performance to all other pairwise combinations of the four biomarkers.
Elevated levels of MLR and NLR were independent predictors of long-term MACE in patients with NSTEMI. Moreover, the combination of MLR and NLR could improve the prognostic value in predicting long-term MACE.
本研究旨在评估单核细胞与淋巴细胞比值(MLR)与中性粒细胞与淋巴细胞比值(NLR)联合用于预测接受直接经皮冠状动脉介入治疗(PCI)的非 ST 段抬高型心肌梗死(NSTEMI)患者长期主要不良心脏事件(MACE)的预后价值。
回顾性队列研究。
中国北京民航总医院。
纳入 2010 年 7 月至 2015 年 7 月期间接受直接 PCI 的 678 例 NSTEMI 患者。
主要观察终点为 MACE。通过 Kaplan-Meier 分析计算累积无 MACE 生存率,采用 Cox 回归分析评估 MACE 的独立预测因素。
根据 MLR 0.36 和 NLR 2.15 的截断值,将研究人群分为四组:低 MLR+低 NLR 组(n=319)、低 MLR+高 NLR 组(n=126)、高 MLR+低 NLR 组(n=102)和高 MLR+高 NLR 组(n=131)。高 MLR+高 NLR 组的无 MACE 生存率低于其他三组(p logrank<0.001)。MLR(HR 2.128,95%CI 1.458 至 3.105)和 NLR(HR 1.925,95%CI 1.385 至 2.676)均为长期 MACE 的独立预测因素。此外,与低 MLR+低 NLR 组相比,高 MLR+高 NLR 组的长期 MACE 风险比(HR)为 4.055(95%CI 2.550 至 6.448)。比较受试者工作特征曲线发现,与 MLR、NLR、高敏 C 反应蛋白和脑钠肽单独相比,MLR 与 NLR 的联合应用在区分长期 MACE 方面具有更好的性能,且与四个标志物的其他两两组合相比性能相当。
在 NSTEMI 患者中,MLR 和 NLR 水平升高是长期 MACE 的独立预测因素。此外,MLR 与 NLR 的联合应用可提高预测长期 MACE 的预后价值。